First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers
Clinical trial NCT02334449 · COMPLETED
Trial details
- NCT number
- NCT02334449
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.